Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

286 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and Safety of Intra-Class Switching from Ixekizumab to Secukinumab in Patients with Plaque Psoriasis: A Multicenter Retrospective Study.
Bernardini N, Dattola A, Rossi R, Pagnanelli G, Amerio P, Atzori L, Mugheddu C, Lora V, Giordano D, Guacci LF, Persechino S, Richetta AG, Skroza N, Potenza C. Bernardini N, et al. Among authors: amerio p. J Pers Med. 2024 Dec 22;14(12):1169. doi: 10.3390/jpm14121169. J Pers Med. 2024. PMID: 39728081 Free PMC article.
"Sorting hat" flap as a modification of the classic A-T flap.
Gualdi G, Petruzzellis A, Ariasi C, Amerio P, Monari P. Gualdi G, et al. Among authors: amerio p. Dermatol Reports. 2024 Feb 7;16(4):9907. doi: 10.4081/dr.2024.9907. eCollection 2024 Nov 21. Dermatol Reports. 2024. PMID: 39687691 Free PMC article.
Efficacy and Safety of Nemolizumab in Patients With Moderate to Severe Prurigo Nodularis: The OLYMPIA 1 Randomized Clinical Phase 3 Trial.
Ständer S, Yosipovitch G, Legat FJ, Reich A, Paul C, Simon D, Naldi L, Metz M, Tsianakas A, Pink A, Fage S, Micali G, Weisshaar E, Sundaram H, Metelitsa A, Augustin M, Wollenberg A, Homey B, Fargnoli MC, Sofen H, Korman NJ, Skov L, Chen X, Jabbar-Lopez ZK, Piketty C, Kwatra SG; OLYMPIA 1 Investigators. Ständer S, et al. JAMA Dermatol. 2024 Nov 27. doi: 10.1001/jamadermatol.2024.4796. Online ahead of print. JAMA Dermatol. 2024. PMID: 39602139
Secukinumab in the Treatment of Psoriasis: A Narrative Review on Early Treatment and Real-World Evidence.
Malagoli P, Dapavo P, Amerio P, Atzori L, Balato A, Bardazzi F, Bianchi L, Cattaneo A, Chiricozzi A, Congedo M, Fargnoli MC, Giofrè C, Gisondi P, Guarneri C, Lembo S, Loconsole F, Mazzocchetti G, Mercuri SR, Morrone P, Offidani AM, Palazzo G, Parodi A, Pellacani G, Piaserico S, Potenza C, Prignano F, Romanelli M, Savoia P, Stingeni L, Travaglini M, Trovato E, Venturini M, Zichichi L, Costanzo A. Malagoli P, et al. Among authors: amerio p. Dermatol Ther (Heidelb). 2024 Oct;14(10):2739-2757. doi: 10.1007/s13555-024-01255-4. Epub 2024 Sep 24. Dermatol Ther (Heidelb). 2024. PMID: 39316358 Free PMC article. Review.
Risankizumab efficacy and safety in psoriatic patients with latent tuberculosis infection: A multicentric real-world study.
Raimondo A, Amerio P, Balato A, Cusano F, Fargnoli MC, Guarneri C, Ligrone L, Megna M, Musumeci ML, Puca RV, Uzzauto MT, Lembo S. Raimondo A, et al. Among authors: amerio p. J Eur Acad Dermatol Venereol. 2024 Sep 13. doi: 10.1111/jdv.20341. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 39269027 No abstract available.
286 results